Phase 1 trial evaluating safety and tolerability of BAL2062 with single and multiple ascending intravenous doses
Latest Information Update: 24 Oct 2023
At a glance
- Drugs VL 2397 (Primary)
- Indications Invasive bronchopulmonary aspergillosis
- Focus Adverse reactions
Most Recent Events
- 24 Oct 2023 New trial record